Guarda G, Zenger M, Yazdi AS, et al. Differential expression of NLRP3 among hematopoietic cells. J Immunol.
2011;186(4):2529-2534.
Dupaul-Chicoine J, Arabzadeh A, Dagenais M, et al. The Nlrp3 inflammasome suppresses colorectal cancer
metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity.
2015;43(4):751-763.
Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3 inflammasome in dendritic cells induces
IL-1β–dependent adaptive immunity against tumors. Nat Med. 2009;15(10):1170-1178.
Shao B-Z, Xu Z-Q, Han B-Z, Su D-F, Liu C. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol.
2015;6:262. doi:10.3389/fphar.2015.00262.
Embry CA, Franchi L, Nuñez G, Mitchell TC. Mechanism of impaired NLRP3 inflammasome priming by
monophosphoryl lipid A. Sci Signal. 2011;4(171):ra28. doi:10.1126/scisignal.2001486.
Sharma D, Kanneganti T-D. The cell biology of inflammasomes: mechanisms of inflammasome activation and
regulation. J Cell Biol. 2016;213(6):617-629.
Chow MT, Möller A, Smyth MJ. Inflammation and immune surveillance in cancer. Semin Cancer Biol.
2012;22(1):23-32.
He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
2016;41(12):1012-1021.
Ben-Sasson SZ, Hogg A, Hu-Li J, et al. IL-1 enhances expansion, effector function, tissue localization, and
memory response of antigen-specific CD8 T cells. J Exp Med. 2013;210(3):491-502.
Maltez VI, Tubbs AL, Cook KD, et al. Inflammasomes coordinate pyroptosis and natural killer cell
cytotoxicity to clear infection by a ubiquitous environmental bacterium. Immunity. 2015;43(5):987-997.
Freeman BE, Hammarlund E, Raué H-P, Slifka MK. Regulation of innate CD8+ T-cell activation mediated by
cytokines. Proc Natl Acad Sci U S A. 2012;109(25):9971-9976.
Cooper MA, Fehniger TA, Ponnappan A, Mehta V, Wewers MD, Caligiuri MA. Interleukin-1β costimulates
interferon-γ production by human natural killer cells. Eur J Immunol. 2001;31(3):792-801.
Chow MT, Sceneay J, Paget C, et al. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors
and metastases. Cancer Res. 2012;72(22):5721-5732.